Arrowstreet Capital’s Radius Health, Inc. RDUS Stock Holding History

Arrowstreet Capital’s Portfolio RDUS Stock Details RDUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-97,205	Closed	-$1.21M	–	1829
2021 Q3	$1.21M	Sell	97,205 -247,217	-72%	-$3.56M	﹤0.01%	1257
2021 Q2	$6.28M	Buy	344,422 +46,482	+16%	+$924K	0.01%	992
2021 Q1	$6.21M	Buy	297,940 +149,360	+101%	+$3.15M	0.01%	1081
2020 Q4	$2.65M	Sell	148,580 -33,030	-18%	-$496K	﹤0.01%	1495
2020 Q3	$2.06M	Buy	+181,610	New	+$2.24M	﹤0.01%	1535
2020 Q1	–	Sell	-145,314	Closed	-$2.93M	–	2204
2019 Q4	$2.93M	Buy	145,314 +121,900	+521%	+$2.96M	0.01%	1015
2019 Q3	$603K	Buy	+23,414	New	+$574K	﹤0.01%	1280

Other funds holding RDUS

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital's RDUS Position: Q4 2021 in Review

Arrowstreet Capital sold out of Radius Health, Inc. (RDUS) in Q4 2021, closing a stake of 97,205 shares — an estimated $1.21M sold.

Arrowstreet Capital first reported a position in RDUS in Q3 2019 and held it in 7 quarters. The position peaked at $6.28M in Q2 2021. 135 funds tracked by Wall St. Rank hold RDUS as of Q4 2021.

Arrowstreet Capital reported no remaining Radius Health, Inc. position as of Q4 2021 after selling out during the quarter.
Arrowstreet Capital sold 97,205 Radius Health, Inc. shares in Q4 2021, an estimated $1.21M.
Arrowstreet Capital first reported a position in Radius Health, Inc. in Q3 2019 and held it in 7 quarters.
Arrowstreet Capital's Radius Health, Inc. position peaked at $6.28M in Q2 2021.
135 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2021.

Based on Arrowstreet Capital's 13F filing for Q4 2021, filed 14 Feb 2022.